Literature DB >> 9178022

Time trends in obesity: an epidemiological perspective.

J C Seidell1.   

Abstract

The average prevalence of obesity (BMI > 30 kg/m2) among European centers participating in the WHO-MONICA study between 1983 and 1986 was about 15% in men and 22% in women Prevalence figures ranged in men from 7% in Gothenburg and 22% in Lithuania and in women from 9% to 45% in the same places. Some monitoring projects or repeated surveys suggest that the prevalence of obesity has been increasing during the past 15 years in some European countries. A closer look at data from The Netherlands suggest that average weight increase in the order of about 1 kilo can be responsible for quite dramatic increases in the prevalence of obesity. This suggest that only small changes in the daily caloric balance may be sufficient to increase the number of obese subjects in populations. In The Netherlands a decrease in energy intake and fat consumption was observed between 1987 and 1993 and smoking rates remained relatively stable. This could imply that reductions in energy expenditure are the main factors responsible for the increase in the prevalence of obesity. Since the increase in the prevalence of obesity seems to occur particularly in younger age-groups, the consequences of the increase in the prevalence of obesity only become apparent many years later. Especially chronic conditions such as arthritis or conditions related to obesity but occurring later in life such as cerebrovascular accidents, chronic heart failure or breast cancer in women. The rising prevalence of non-insulin dependent diabetes mellitus may be one of the first signs of the increasing problem of obesity in European countries.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9178022     DOI: 10.1055/s-2007-979011

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  20 in total

Review 1.  A risk-benefit assessment of anti-obesity drugs.

Authors:  J Kolanowski
Journal:  Drug Saf       Date:  1999-02       Impact factor: 5.606

2.  Food habits of Canadians: reduction in fat intake over a generation.

Authors:  K Gray-Donald; L Jacobs-Starkey; L Johnson-Down
Journal:  Can J Public Health       Date:  2000 Sep-Oct

Review 3.  Effects of obesity on pharmacokinetics implications for drug therapy.

Authors:  G Cheymol
Journal:  Clin Pharmacokinet       Date:  2000-09       Impact factor: 6.447

4.  Socioeconomic status and obesity among semi-urban Nigerians.

Authors:  Chidozie E Mbada; Rufus A Adedoyin; Olusola Ayanniyi
Journal:  Obes Facts       Date:  2009-10-19       Impact factor: 3.942

5.  A cross-sectional study of sarcopenia in Japanese men and women: reference values and association with cardiovascular risk factors.

Authors:  K Sanada; M Miyachi; M Tanimoto; K Yamamoto; H Murakami; S Okumura; Y Gando; K Suzuki; I Tabata; M Higuchi
Journal:  Eur J Appl Physiol       Date:  2010-09       Impact factor: 3.078

6.  The cost of obesity in Canada.

Authors:  C L Birmingham; J L Muller; A Palepu; J J Spinelli; A H Anis
Journal:  CMAJ       Date:  1999-02-23       Impact factor: 8.262

7.  High obesity incidence in northern Sweden: how will Sweden look by 2009?

Authors:  Anne N Nafziger; Hans Stenlund; Stig Wall; Paul L Jenkins; Vivan Lundberg; Thomas A Pearson; Lars Weinehall
Journal:  Eur J Epidemiol       Date:  2006-06-09       Impact factor: 8.082

8.  No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.

Authors:  Troy C Sarich; Renli Teng; Gary R Peters; Maria Wollbratt; Robert Homolka; Mia Svensson; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Obesity prevalence in Nepal: public health challenges in a low-income nation during an alarming worldwide trend.

Authors:  Abhinav Vaidya; Suraj Shakya; Alexandra Krettek
Journal:  Int J Environ Res Public Health       Date:  2010-06-23       Impact factor: 3.390

10.  Maternal high fat diet during pregnancy and lactation alters hepatic expression of insulin like growth factor-2 and key microRNAs in the adult offspring.

Authors:  Junlong Zhang; Fang Zhang; Xavier Didelot; Kimberley D Bruce; Felino R Cagampang; Manu Vatish; Mark Hanson; Hendrik Lehnert; Antonio Ceriello; Christopher D Byrne
Journal:  BMC Genomics       Date:  2009-10-16       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.